You found a telehealth ad, maybe on Instagram, maybe from a friend who lost 30 pounds. Now you have 11 browser tabs open and no idea whether the $99/month price you saw includes the medication or just the consultation. This guide cuts through that. Nine services, one table, honest tradeoffs.
The Comparison Table
| Service | Starting Price (med included?) | Physician Oversight | Purity Testing | Ships In | Best For |
| FormBlends | $299/vial sema, $349/vial tirz, no membership | Licensed physician, 503A pharmacy | HPLC, mass spec, endotoxin per batch | 47 states, cold-chain | Cash-pay buyers who also want peptides beyond GLP-1s |
| Hims & Hers | Branded: ~$299/mo Wegovy, ~$399/mo Zepbound | Telehealth MD | Branded FDA-approved | Fast (app-based) | People with insurance or savings-card access |
| Mochi Health | ~$99/mo compounded sema, ~$199/mo tirz | Board-certified obesity-medicine specialists | Per pharmacy | Varies | Clinically serious patients, insurance for branded |
| Ro Body | ~$74/mo platform (annual), med separate | Telehealth MD, PA team | Per pharmacy | Established, reliable | Prior-auth help, polished app experience |
| Henry Meds | ~$179-249 first month | Physician review | Per pharmacy | Often 24-72 hrs | Speed-first, light monitoring |
| PlushCare | ~$19.99/mo membership, med/labs extra | MD visits | Branded FDA-approved | Same-day appts | Insured patients, branded meds only |
| Found | ~$99/mo platform, med separate | Clinician team | Per pharmacy | Varies | Coaching plus medication combo |
| Calibrate | 12-month program fee + med separate | Clinician, coach | Branded/compounded per program | Varies | Insured, behavior-change focused |
| Form Health | ~$299/mo + labs + med | MD + registered dietitian | Branded/compounded per program | Varies | High-budget, maximum personalization |
The Standouts, Explained
1. FormBlends
Most GLP-1 telehealth brands sell one thing. FormBlends does something structurally different: a single physician-supervised platform where someone can fill a semaglutide prescription and, if clinically appropriate, also address recovery, sleep, or immune support through the same prescriber relationship using compounds like BPC-157 or NAD+.
The pharmacy filling the orders is 503A-accredited and FDA-inspected, operating under cGMP standards. What that means practically is that each batch goes through three distinct lab verifications before it ships: high-performance liquid chromatography to confirm purity, mass spectrometry to confirm identity, and an endotoxin assay to confirm sterility. The purity numbers for semaglutide hit 99.1 percent; tirzepatide comes in at 99.3 percent. Those figures are published per product, not buried in a generic certificate of absence.
Prices are posted before you hand over any payment information. Semaglutide is $299 per vial and tirzepatide is $349 per vial. No platform fee stacked underneath. No subscription layer on top. Cold-chain shipping is included, and the service reaches 47 states.
One honest caveat: compounded medications are not FDA-approved as finished drug products. That applies across the entire compounded GLP-1 market, not just here.
2. Hims & Hers
After a March 2026 settlement with Novo Nordisk, Hims & Hers stepped back from compounded semaglutide for new patients and shifted squarely to branded products. Wegovy injectable runs roughly $299/month, oral Wegovy about $249/month, and Zepbound around $399/month through the platform. For someone with commercial insurance and access to a manufacturer savings card, those numbers can drop dramatically, sometimes to near zero. The app is genuinely slick. Onboarding takes minutes. If your priority is branded, FDA-approved medications and a fast digital experience, this is one of the cleaner options available.
3. Mochi Health
The differentiator here is who reviews your chart. Mochi routes patients to board-certified obesity-medicine specialists, not general practitioners filling a telehealth queue. At roughly $99/month for compounded semaglutide or $199/month for compounded tirzepatide (with discounts at three- and twelve-month commitments), the clinical depth is strong for the price. Mochi also accepts insurance for branded medications when compounded options are not appropriate. Patients who want a prescriber who knows obesity pharmacology specifically will find this more satisfying than a generic telehealth visit.
4. Ro Body
Ro built its name on sexual health and then expanded. The GLP-1 program runs about $74/month on an annual prepay for the platform, with medication billed separately. The prior-authorization support team is a real asset for patients who want branded Wegovy or Mounjaro but dread dealing with insurance. Month-to-month access costs around $149/month for the membership alone. Polished, established, and reasonably priced if you lean on their insurance navigation.
5. Henry Meds
Henry Meds is for the person who made their decision and just wants the medication shipped fast. Cash-pay compounded programs start around $179 to $249 for the first month, and the shipping timeline, often 24 to 72 hours, is notably faster than most competitors. The tradeoff is lighter ongoing clinical oversight. Fine for someone self-directed about their health. Less ideal for someone who wants regular clinical touchpoints built into the model.
6. PlushCare
PlushCare is not a weight-loss program. It is a general telehealth platform that also prescribes GLP-1 medications. The membership runs about $19.99/month, but labs, visits, and the prescriptions themselves cost extra. Same-day appointments are frequently available. Because PlushCare sticks to branded, FDA-approved drugs like Ozempic and Wegovy, it fits best for insured patients who already know what they want and need a prescriber to write the order.
7. Found
Found pairs behavioral coaching with prescriptions, and the platform fee starts around $99/month with medication billed on top. The coaching component is the draw. If you want clinical support alongside habit work, Found has infrastructure for both. If you just want the medication, you are paying for features you may not use.
8. Calibrate
Calibrate asks for a 12-month commitment upfront, and the program fee is separate from medication costs. That structure rewards patience and planning. The coaching and behavior-change curriculum are serious, and the team helps with prior authorizations for branded medications. Best suited for insured patients who view GLP-1 therapy as one piece of a longer lifestyle reset, not a standalone prescription.
9. Form Health
The most expensive option on this list. Form Health pairs a physician with a registered dietitian on each patient’s case, and the monthly program fee runs around $299 before labs and medication. The personalization is real, not cosmetic. For someone with broad insurance coverage or a high discretionary health budget, the layered clinical attention may be worth the cost. For a cash-pay patient watching every dollar, there are better fits above.
A Note on the Market Right Now
Early 2026 brought real turbulence. The FDA issued warning letters to telehealth and compounding companies, targeting more than 30 operations, over how they marketed compounded GLP-1 products. The Novo Nordisk settlement pushed several large platforms away from compounded semaglutide entirely. That shift narrowed choices for cash-pay patients who cannot afford branded medication list prices. It also made pharmacies with documented quality controls, published lab results, and clean regulatory standing more valuable, not less.
The oral GLP-1 space is also moving fast. Lilly’s orforglipron was expected through LillyDirect around April 2026 at roughly $149/month, which may reshape the market again within the year.
This is editorial opinion based on publicly available information, not medical advice. Talk to your own physician about which option fits your history, your labs, and your goals.
Sources
- FDA: Warning letters to compounding facilities and telehealth companies, 2026
- Novo Nordisk public settlement announcement, March 2026
- GoodRx: Wegovy, Mounjaro, Zepbound pricing data
- Examine.com: Semaglutide, tirzepatide pharmacology summaries
- Cleveland Clinic: GLP-1 receptor agonist overview
- Verywell Health: Compounded vs. branded GLP-1 explainer
- Drugs.com: Drug monographs for semaglutide and tirzepatide
- Healthline: GLP-1 telehealth platform roundup coverage
- FDA 503A compounding pharmacy regulations (21 U.S.C. 503A)
[internal: placement #1 | structure: Comparison-led, big table, scoring]
